KLOW Blend (80 mg) Research Peptide – Overview
The KLOW Blend (80 mg) Research Peptide is a proprietary mixture of three synergistic peptide fragments (Ipamorelin, GHRP‑2 and a patented “K‑sequence”) designed to amplify endogenous growth‑hormone release while minimizing cortisol spikes. GMP‑certified and ≥ 99 % pure (HPLC), it is endotoxin‑free and the go‑to tool for muscle‑growth, anti‑aging and metabolic‑signalling research.
Key Benefits
- Potent GH‑secretagogue blend – boosts lean‑mass gain with minimal side‑effects.
- High purity – ≥ 99 % purity confirmed by HPLC.
- Versatile applications – suitable for in‑vitro cell culture, rodent models and ex‑vivo tissue assays.
Technical Specifications
| Specification |
Detail |
| Blend composition |
Ipamorelin + GHRP‑2 + K‑sequence (proprietary) |
| Quantity |
80 mg per amber vial |
| Purity |
≥ 99 % (HPLC) |
| Form |
Lyophilized powder, amber glass vial (4 mL reconstitution volume) |
| Storage |
–20 °C, desiccated; protect from light & moisture |
| Shelf‑life |
24 months when stored as recommended |
| SKU |
PL‑KLOW‑80‑MG |
| GTIN / UPC |
019876543234 |
| Manufacturer |
PrymaLab |
Reconstitution & Recommended Use
- Reconstitute the vial with **4 mL sterile bacteriostatic water** → final concentration **20 mg / mL** (20 000 µg / mL). This yields a ready‑to‑use solution of the KLOW Blend 80 mg Research Peptide.
- In‑vitro dose: **50‑500 µg/mL** added to culture medium (adjust per assay).
- In‑vivo rodent dose: **0.5‑2 mg/kg** sub‑cutaneously, once daily or split BID.
- Maximum single dose: **80 mg** per animal per day.
Safety Disclaimer
This product is supplied for **personal, non‑clinical research use only**. It is **not a medication** and does **not** diagnose, treat, cure or prevent any disease. Pregnant or nursing individuals, people with known medical conditions, or anyone taking prescription medication should consult a qualified health professional before use. Keep out of reach of children.